Israel - Ibrani - Ministry of Health

j-c health care ltd - darunavir as ethanolate - טבליות מצופות פילם - darunavir as ethanolate 400 mg - darunavir - darunavir - prezista , co-administered with 100 mg ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.

Israel - Ibrani - Ministry of Health

j-c health care ltd - darunavir as ethanolate - טבליות מצופות פילם - darunavir as ethanolate 600 mg - darunavir - darunavir - prezista , co-administered with 100 mg ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.

Israel - Ibrani - Ministry of Health

j-c health care ltd - darunavir as ethanolate - טבליות מצופות פילם - darunavir as ethanolate 75 mg - darunavir - darunavir - adult patients : prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv -1) infection. this indication is based on analyses of plasma hiv rna levels and cd4+ cell counts from 2 controlled phase 3 trials of 48 weeks duration in antiretroviral treatment - naive and treatment -experienced patients and 2 controlled phase 2 trials of 96 weeks duration in clinically advanced, treatment -experienced adult patients .pediatric patients :prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of hiv in pediatric patients 6 years of age and older. this indication is based on week 24 analyses of plasma hiv rna levels and cd4+ cell counts from an open-label phase 2 trial in antiretroviral treatment -experienced pediatric patients 6 to < 18 years of age. in treatment-experienced adult and pediatric the following points should be considered when ini

Israel - Ibrani - Ministry of Health

j-c health care ltd - darunavir as ethanolate - טבליות מצופות פילם - darunavir as ethanolate 150 mg - darunavir - darunavir - adult patients : prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv -1) infection. this indication is based on analyses of plasma hiv rna levels and cd4+ cell counts from 2 controlled phase 3 trials of 48 weeks duration in antiretroviral treatment - naive and treatment -experienced patients and 2 controlled phase 2 trials of 96 weeks duration in clinically advanced, treatment -experienced adult patients .pediatric patients :prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of hiv in pediatric patients 6 years of age and older. this indication is based on week 24 analyses of plasma hiv rna levels and cd4+ cell counts from an open-label phase 2 trial in antiretroviral treatment -experienced pediatric patients 6 to < 18 years of age. in treatment-experienced adult and pediatric the following points should be considered when ini

Israel - Ibrani - Ministry of Health

vetmarket ltd, israel - diethanolamine fusidate; framycetin sulfate; nystatin; prednisolone - טיפות - framycetin sulfate 5 mg/g; prednisolone 2.5 mg/g; nystatin 100000 units / 1 g; diethanolamine fusidate 5 mg/g

Israel - Ibrani - Ministry of Health

j-c health care ltd - cobicistate; darunavir as ethanolate - טבליות מצופות פילם - cobicistate 150 mg; darunavir as ethanolate 800 mg - darunavir

Israel - Ibrani - Ministry of Health

ben shimon floris ltd, israel - alcohol - תמיסה - alcohol 70 %v/v - ethanol - ethanol - antiseptic.

Israel - Ibrani - Ministry of Health

remedix care ltd - ascorbic acid; biotin; cocarboxylase tetrahydrate; colecalciferol; cyanocobalamin; dexpanthenol; folic acid; nicotinamide; pyridoxine (vit b6) hydrochloride; retinol palmitate; riboflavine; tocopherol - אבקה להכנת תמיסה לזריקה - retinol palmitate 3500 iu/vial; colecalciferol 220 iu/vial; tocopherol 10.2 mg/vial; ascorbic acid 125 mg/vial; riboflavine 5.67 mg/vial; pyridoxine (vit b6) hydrochloride 5.5 mg/vial; cyanocobalamin 0.006 mg/vial; folic acid 0.414 mg/vial; dexpanthenol 16.15 mg/vial; biotin 0.069 mg/vial; nicotinamide 46 mg/vial; cocarboxylase tetrahydrate 5.8 mg/vial - combinations - combinations - vitamin supplementation in patients receiving parenteral nutrition. only for adults and children over 11 years of age.

Israel - Ibrani - Ministry of Health

remedix care ltd - ascorbic acid; biotin; cocarboxylase tetrahydrate; colecalciferol; cyanocobalamin; dexpanthenol; folic acid; nicotinamide; pyridoxine (vit b6) hydrochloride; retinol palmitate; riboflavine; tocopherol - אבקה להכנת תמיסה לזריקה - retinol palmitate 3500 iu/vial; colecalciferol 220 iu/vial; tocopherol 10.2 mg/vial; ascorbic acid 125 mg/vial; riboflavine 5.67 mg/vial; pyridoxine (vit b6) hydrochloride 5.5 mg/vial; cyanocobalamin 0.006 mg/vial; folic acid 0.414 mg/vial; dexpanthenol 16.15 mg/vial; biotin 0.069 mg/vial; nicotinamide 46 mg/vial; cocarboxylase tetrahydrate 5.8 mg/vial - combinations

Israel - Ibrani - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - rotavirus g1 reassortant; rotavirus g2 reassortant; rotavirus g3 reassortant; rotavirus g4 reassortant; rotavirus p1a[8] reassortant - suspension - rotavirus p1a[8] reassortant 2.3 x10 ^6 iu/dose; rotavirus g2 reassortant 2.8 x10 ^6 iu/dose; rotavirus g4 reassortant 2.0 x10^ 6 iu/dose; rotavirus g3 reassortant 2.2 x10 ^6 iu/dose; rotavirus g1 reassortant 2.2 x10 ^6 iu/dose - rota virus diarrhea vaccines - rotateq is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by the serotypes g1, g2, g3, and g4 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks. the first dose of rorateq should be administered betwen 6 and 12 weeks of age.